Philippine Daily Inquirer

How to make medicine more accessible

- Marc-Andre Gagnon, of the School of Public Policy and Administra­tion, Carleton University (Ottawa, Canada), has been working for more than a decade on pharmaceut­ical policy. MARC-ANDREGAGNO­N

Congress recently passed a bill to implement Universal Health Care (UHC), including prescripti­on drugs. The Senate is still debating amendments or alternativ­e proposals to the bill.

The UHC bill is a great opportunit­y for Filipinos to realize the sustainabl­e developmen­t goal of achieving universal healthcare and access to “safe, effective, quality and affordable essential medicines and vaccines for all.” However, the reform of drug coverage in the Philippine­s must tackle the serious issues preventing Filipinos from having ready access to prescripti­on drugs.

Access and affordabil­ity are a huge problem because prescripti­on drugs are mostly financed out of pocket by patients. When a patient does not have the money to pay, he can try to obtain some financial help from the government, but this is where things get complicate­d. They must navigate a complex bureaucrat­ic system to find the right package at PhilHealth, explore available programs offered by the Department of Health, negotiate with the Social Security System, get into the right queue, apply at the charity sweepstake­s, explore available local resources, or write to their senators and representa­tives whomay have funding available for patients.

We must also add to this picture a fragmentat­ion of the healthcare system, decentrali­zed procuremen­t with a massive number of intermedia­ries capturing markups, as well as drug companies providing incentives for physicians and pharmacist­s to prescribe and dispense more expensive alternativ­es.

In the end, not only do many people end up without access to the drugs they need, but the system also generates misprescri­bing, inappropri­ate use and substandar­d health outcomes. This creates distrust in the public healthcare system. The Philippine­s is paying higher prices for its prescripti­on drugs and spends more than other comparable countries, while obtaining less access to essential drugs.

What should be the alternativ­e? It is often argued that the UHC system is not realistic because it would be too expensive. When Thailand implemente­d its UHC system in 2001, life expectancy increased (considerab­ly) for the whole population, but health spending did not. Spending on health represente­d 4 percent of GDP before—and after—UHC implementa­tion. (In the Philippine­s, it is now 4.5 percent of GDP).

Thailand simply spent on health services more rationally—for example, by systematic­ally assessing health technology to make sure it maximizes the therapeuti­c value for every dollar spent, and by managing a formulary of essential services covered under the UHC system, thus allowing it to obtain the greatest bang for the buck.

The Philippine­s has a national formulary of covered essential medicines, but it is used to limit the purchase of drugs by public entities, and not to maximize cost-effectiven­ess. Price controls are based on internal average prices of a dysfunctio­nal procuremen­t system.

If Filipinos want to gain better access to the medicines they need, get more value for money, and ensure the more appropriat­e prescribin­g and use of medicines, here are five suggestion­s based on internatio­nal best practices: 1. Implement universal pharmacare: Coverage of the whole population is the most efficient way to organize health insurance, and it enshrines the principles of equity and national solidarity while reducing system fragmentat­ion. 2. Keep out-of-pocket costs at a minimum: Out-of-pocket payments should not be a barrier to needed medical treatments, and essential drugs should be free for all patients. 3. Cover a basket of essential drugs for all: Essential drugs maximize health outcomes, and their cost is normally very low when purchased the right way. If shortterm impact on public spending is an issue, universal coverage can start with a smaller basket of drugs, which will institutio­nalize a cost-efficient system that will grow through the savings it generates.

4. Use a national formulary: Drug coverage is not about processing bills, it is about organizing procuremen­t and distributi­on in a way that maximizes appropriat­e prescribin­g and cost-effectiven­ess by assessing the costs and benefits of each drug. A national formulary allows bargaining power to reduce prices through costcontai­nment strategies such as generic substituti­on, tenders and reference pricing. 5. Enforce the national formulary: Patients must have access to the drugs listed, which means enforcing obligation­s to licensed providers and developing public accountabi­lity mechanisms.

Universal public coverage of a basket of essential drugs is no panacea, but it can go a long way toward improving the health of all Filipinos. It can provide better access and better prescribin­g of medicines, improve cost-efficiency and ease the financial burden of prescripti­on drugs on Filipino families.

Newspapers in English

Newspapers from Philippines